-
1
-
-
79953200515
-
Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats
-
B. Chen, A. Moore, L.V. Escobedo, M.S. Koletsky, D. Hou, R.J. Koletsky, and P. Ernsberger Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats Exp. Biol. Med. (Maywood) 236 2011 309 314
-
(2011)
Exp. Biol. Med. (Maywood)
, vol.236
, pp. 309-314
-
-
Chen, B.1
Moore, A.2
Escobedo, L.V.3
Koletsky, M.S.4
Hou, D.5
Koletsky, R.J.6
Ernsberger, P.7
-
2
-
-
79960987925
-
Cardiovascular effects of glucagonlike peptide-1 agonists
-
M.H. Davidson Cardiovascular effects of glucagonlike peptide-1 agonists Am. J. Cardiol. 108 2011 33B 41B
-
(2011)
Am. J. Cardiol.
, vol.108
-
-
Davidson, M.H.1
-
3
-
-
34147161322
-
Dipeptidyl peptidase 4 inhibition with sitagliptin: A new therapy for Type 2 diabetes
-
DOI 10.1517/13543784.16.4.533
-
C.F. Deacon Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for type 2 diabetes Expert Opin. Investig. Drugs 16 2007 533 545 (Pubitemid 46554470)
-
(2007)
Expert Opinion on Investigational Drugs
, vol.16
, Issue.4
, pp. 533-545
-
-
Deacon, C.F.1
-
4
-
-
77958195997
-
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: Possible role of stromal-derived factor-1alpha
-
G.P. Fadini, E. Boscaro, M. Albiero, L. Menegazzo, V. Frison, S. de Kreutzenberg, C. Agostini, A. Tiengo, and A. Avogaro The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha Diabetes Care 33 2010 1607 1609
-
(2010)
Diabetes Care
, vol.33
, pp. 1607-1609
-
-
Fadini, G.P.1
Boscaro, E.2
Albiero, M.3
Menegazzo, L.4
Frison, V.5
De Kreutzenberg, S.6
Agostini, C.7
Tiengo, A.8
Avogaro, A.9
-
5
-
-
77955406467
-
Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat)
-
L. Ferreira, E. Teixeira-de-Lemos, F. Pinto, B. Parada, C. Mega, H. Vala, R. Pinto, P. Garrido, J. Sereno, R. Fernandes, P. Santos, I. Velada, A. Melo, S. Nunes, F. Teixeira, and F. Reis Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat) Mediat. Inflamm. 2010 2010 592760
-
(2010)
Mediat. Inflamm.
, vol.2010
, pp. 592760
-
-
Ferreira, L.1
Teixeira-De-Lemos, E.2
Pinto, F.3
Parada, B.4
Mega, C.5
Vala, H.6
Pinto, R.7
Garrido, P.8
Sereno, J.9
Fernandes, R.10
Santos, P.11
Velada, I.12
Melo, A.13
Nunes, S.14
Teixeira, F.15
Reis, F.16
-
6
-
-
84859444000
-
Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model
-
A. Goncalves, E. Leal, A. Paiva, E. Teixeira Lemos, F. Teixeira, C.F. Ribeiro, F. Reis, A.F. Ambrosio, and R. Fernandes Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model Diabetes Obes. Metab. 14 2012 454 463
-
(2012)
Diabetes Obes. Metab.
, vol.14
, pp. 454-463
-
-
Goncalves, A.1
Leal, E.2
Paiva, A.3
Teixeira Lemos, E.4
Teixeira, F.5
Ribeiro, C.F.6
Reis, F.7
Ambrosio, A.F.8
Fernandes, R.9
-
7
-
-
84872166617
-
Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice?
-
B. Hemmeryckx, M.F. Hoylaerts, D.J. Gallacher, Lu, H. Rong, U. Himmelreich, J. D'Hooge, M. Swinnen, and H.R. Lijnen Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice? Eur. J. Pharmacol. 700 2013 23 31
-
(2013)
Eur. J. Pharmacol.
, vol.700
, pp. 23-31
-
-
Hemmeryckx, B.1
Hoylaerts, M.F.2
Gallacher, D.J.3
Rong, L.H.4
Himmelreich, U.5
D'Hooge, J.6
Swinnen, M.7
Lijnen, H.R.8
-
8
-
-
79251623618
-
Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males
-
G.A. Herman, G.C. Mistry, B. Yi, A.J. Bergman, A.Q. Wang, W. Zeng, L. Chen, K. Snyder, J.L. Ruckle, P.J. Larson, M.J. Davies, R.B. Langdon, K.M. Gottesdiener, and J.A. Wagner Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males Br. J. Clin. Pharmacol. 71 2011 429 436
-
(2011)
Br. J. Clin. Pharmacol.
, vol.71
, pp. 429-436
-
-
Herman, G.A.1
Mistry, G.C.2
Yi, B.3
Bergman, A.J.4
Wang, A.Q.5
Zeng, W.6
Chen, L.7
Snyder, K.8
Ruckle, J.L.9
Larson, P.J.10
Davies, M.J.11
Langdon, R.B.12
Gottesdiener, K.M.13
Wagner, J.A.14
-
9
-
-
37149019633
-
Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling
-
E.G. Hong, D.Y. Jung, H.J. Ko, Z. Zhang, Z. Ma, J.Y. Jun, J.H. Kim, A.D. Sumner, T.C. Vary, T.W. Gardner, S.K. Bronson, and J.K. Kim Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling Am. J. Physiol. Endocrinol. Metab. 293 2007 E1687 E1696
-
(2007)
Am. J. Physiol. Endocrinol. Metab.
, vol.293
-
-
Hong, E.G.1
Jung, D.Y.2
Ko, H.J.3
Zhang, Z.4
Ma, Z.5
Jun, J.Y.6
Kim, J.H.7
Sumner, A.D.8
Vary, T.C.9
Gardner, T.W.10
Bronson, S.K.11
Kim, J.K.12
-
10
-
-
84872565644
-
The dipeptidyl peptidase-4 inhibitor sitagliptin improves vascular endothelial function in type 2 diabetes
-
Y. Kubota, M. Miyamoto, G. Takagi, T. Ikeda, S. Kirinoki-Ichikawa, K. Tanaka, and K. Mizuno The dipeptidyl peptidase-4 inhibitor sitagliptin improves vascular endothelial function in type 2 diabetes J. Korean Med. Sci. 27 2012 1364 1370
-
(2012)
J. Korean Med. Sci.
, vol.27
, pp. 1364-1370
-
-
Kubota, Y.1
Miyamoto, M.2
Takagi, G.3
Ikeda, T.4
Kirinoki-Ichikawa, S.5
Tanaka, K.6
Mizuno, K.7
-
11
-
-
80055110463
-
Effects of DPP-4 inhibition on cardiac metabolism and function in mice
-
M. Lenski, A. Kazakov, N. Marx, M. Bohm, and U. Laufs Effects of DPP-4 inhibition on cardiac metabolism and function in mice J. Mol. Cell Cardiol. 51 2011 906 918
-
(2011)
J. Mol. Cell Cardiol.
, vol.51
, pp. 906-918
-
-
Lenski, M.1
Kazakov, A.2
Marx, N.3
Bohm, M.4
Laufs, U.5
-
12
-
-
84855854533
-
An alternative approach to understanding the pathophysiological mechanisms of chronic heart failure
-
D.H. MacIver, and M.J. Dayer An alternative approach to understanding the pathophysiological mechanisms of chronic heart failure Int. J. Cardiol. 154 2012 102 110
-
(2012)
Int. J. Cardiol.
, vol.154
, pp. 102-110
-
-
Maciver, D.H.1
Dayer, M.J.2
-
13
-
-
4143052336
-
Second-generation thiazolidinediones and hepatotoxicity
-
DOI 10.1345/aph.1E072
-
T.R. Marcy, M.L. Britton, and S.M. Blevins Second-generation thiazolidinediones and hepatotoxicity Ann. Pharmacother. 38 2004 1419 1423 (Pubitemid 39100194)
-
(2004)
Annals of Pharmacotherapy
, vol.38
, Issue.9
, pp. 1419-1423
-
-
Marcy, T.R.1
Britton, M.L.2
Blevins, S.M.3
-
14
-
-
84861445574
-
Severe hypoglycemia associated with levofloxacin in type 2 diabetic patients receiving polytherapy: Two case reports
-
L. Micheli, M. Sbrilli, and C. Nencini Severe hypoglycemia associated with levofloxacin in type 2 diabetic patients receiving polytherapy: two case reports Int. J. Clin. Pharmacol. Ther. 50 2012 302 306
-
(2012)
Int. J. Clin. Pharmacol. Ther.
, vol.50
, pp. 302-306
-
-
Micheli, L.1
Sbrilli, M.2
Nencini, C.3
-
15
-
-
70350203952
-
Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes
-
J. Mu, A. Petrov, G.J. Eiermann, J. Woods, Y.P. Zhou, Z. Li, E. Zycband, Y. Feng, L. Zhu, R.S. Roy, A.D. Howard, C. Li, N.A. Thornberry, and B.B. Zhang Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes Eur. J. Pharmacol. 623 2009 148 154
-
(2009)
Eur. J. Pharmacol.
, vol.623
, pp. 148-154
-
-
Mu, J.1
Petrov, A.2
Eiermann, G.J.3
Woods, J.4
Zhou, Y.P.5
Li, Z.6
Zycband, E.7
Feng, Y.8
Zhu, L.9
Roy, R.S.10
Howard, A.D.11
Li, C.12
Thornberry, N.A.13
Zhang, B.B.14
-
16
-
-
0344304678
-
Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: A Consensus Statement from the American Heart Association and American Diabetes Association
-
DOI 10.1161/01.CIR.0000103683.99399.7E
-
R.W. Nesto, D. Bell, R.O. Bonow, V. Fonseca, S.M. Grundy, E.S. Horton, M. Le Winter, D. Porte, C.F. Semenkovich, S. Smith, L.H. Young, and R. Kahn Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American heart association and american diabetes association Circulation 108 2003 2941 2948 (Pubitemid 37517824)
-
(2003)
Circulation
, vol.108
, Issue.23
, pp. 2941-2948
-
-
Nesto, R.W.1
Bell, D.2
Bonow, R.O.3
Fonseca, V.4
Grundy, S.M.5
Horton, E.S.6
Le Winter, M.7
Porte, D.8
Semenkovich, C.F.9
Smith, S.10
Young, L.H.11
Kahn, R.12
-
17
-
-
1442311383
-
Effects of Glucagon-Like Peptide-1 in Patients with Acute Myocardial Infarction and Left Ventricular Dysfunction after Successful Reperfusion
-
DOI 10.1161/01.CIR.0000120505.91348.58
-
L.A. Nikolaidis, S. Mankad, G.G. Sokos, G. Miske, A. Shah, D. Elahi, and R.P. Shannon Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion Circulation 109 2004 962 965 (Pubitemid 38282847)
-
(2004)
Circulation
, vol.109
, Issue.8
, pp. 962-965
-
-
Nikolaidis, L.A.1
Mankad, S.2
Sokos, G.G.3
Miske, G.4
Shah, A.5
Elahi, D.6
Shannon, R.P.7
-
19
-
-
39449114610
-
Thiazolidinediones: Effects on insulin resistance and the cardiovascular system
-
DOI 10.1038/sj.bjp.0707452, PII 0707452
-
C.E. Quinn, P.K. Hamilton, C.J. Lockhart, and G.E. McVeigh Thiazolidinediones: effects on insulin resistance and the cardiovascular system Br. J. Pharmacol. 153 2008 636 645 (Pubitemid 351271751)
-
(2008)
British Journal of Pharmacology
, vol.153
, Issue.4
, pp. 636-645
-
-
Quinn, C.E.1
Hamilton, P.K.2
Lockhart, C.J.3
McVeigh, G.E.4
-
20
-
-
33845489598
-
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
-
I. Raz, M. Hanefeld, L. Xu, C. Caria, D. Williams-Herman, and H. Khatami Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus Diabetologia 49 2006 2564 2571
-
(2006)
Diabetologia
, vol.49
, pp. 2564-2571
-
-
Raz, I.1
Hanefeld, M.2
Xu, L.3
Caria, C.4
Williams-Herman, D.5
Khatami, H.6
-
21
-
-
84869141311
-
Sitagliptin reduces hyperglycemia and increases satiety hormone secretion more effectively when used with a novel polysaccharide in obese Zucker rats
-
R.A. Reimer, G.J. Grover, L. Koetzner, R.J. Gahler, P. Juneja, M.R. Lyon, and S. Wood Sitagliptin reduces hyperglycemia and increases satiety hormone secretion more effectively when used with a novel polysaccharide in obese Zucker rats J. Nutr. 142 2012 1812 1820
-
(2012)
J. Nutr.
, vol.142
, pp. 1812-1820
-
-
Reimer, R.A.1
Grover, G.J.2
Koetzner, L.3
Gahler, R.J.4
Juneja, P.5
Lyon, M.R.6
Wood, S.7
-
22
-
-
0040826647
-
Plasma and blood volume in the cow using the T-1824 hematocrit method
-
M. Reynolds Plasma and blood volume in the cow using the T-1824 hematocrit method Am. J. Physiol. 173 1953 421 427
-
(1953)
Am. J. Physiol.
, vol.173
, pp. 421-427
-
-
Reynolds, M.1
-
23
-
-
33847024333
-
Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes
-
R. Scott, M. Wu, M. Sanchez, and P. Stein Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes Int. J. Clin. Pract. 61 2007 171 180
-
(2007)
Int. J. Clin. Pract.
, vol.61
, pp. 171-180
-
-
Scott, R.1
Wu, M.2
Sanchez, M.3
Stein, P.4
-
24
-
-
38949128735
-
Increased Glycation of Hemoglobin in Chronic Renal Failure Patients and Its Potential Role of Oxidative Stress
-
DOI 10.1016/j.arcmed.2008.01.001, PII S0188440908000039
-
N. Selvaraj, Z. Bobby, and M.G. Sridhar Increased glycation of hemoglobin in chronic renal failure: [corrected] potential role of oxidative stress Arch. Med. Res. 39 2008 277 284 (Pubitemid 351221153)
-
(2008)
Archives of Medical Research
, vol.39
, Issue.3
, pp. 277-284
-
-
Selvaraj, N.1
Bobby, Z.2
Sridhar, M.G.3
-
25
-
-
27744608233
-
1c) measurements from frozen whole blood samples stored for over a decade
-
DOI 10.1111/j.1464-5491.2005.01705.x
-
E. Selvin, J. Coresh, J. Jordahl, L. Boland, and M.W. Steffes Stability of hemoglobin A1c (HbA1c) measurements from frozen whole blood samples stored for over a decade Diabet. Med. 22 2005 1726 1730 (Pubitemid 43046475)
-
(2005)
Diabetic Medicine
, vol.22
, Issue.12
, pp. 1726-1730
-
-
Selvin, E.1
Coresh, J.2
Jordahl, J.3
Boland, L.4
Steffes, M.W.5
-
26
-
-
73749083481
-
Global estimates of the prevalence of diabetes for 2010 and 2030
-
J.E. Shaw, R.A. Sicree, and P.Z. Zimmet Global estimates of the prevalence of diabetes for 2010 and 2030 Diabetes Res. Clin. Pract. 87 2010 4 14
-
(2010)
Diabetes Res. Clin. Pract.
, vol.87
, pp. 4-14
-
-
Shaw, J.E.1
Sicree, R.A.2
Zimmet, P.Z.3
-
27
-
-
84874184400
-
A review of the efficacy and safety of oral antidiabetic drugs
-
S.A. Stein, E.M. Lamos, and S.N. Davis A review of the efficacy and safety of oral antidiabetic drugs Expert Opin. Drug Saf. 12 2013 153 175
-
(2013)
Expert Opin. Drug Saf.
, vol.12
, pp. 153-175
-
-
Stein, S.A.1
Lamos, E.M.2
Davis, S.N.3
-
28
-
-
20344363607
-
Adiponectin concentrations as a criterion of metabolic control in persons with type 2 diabetes mellitus?
-
D. Stejskal, V. Ruzicka, S. Adamovska, R. Jurakova, J. Proskova, L. Jedelsky, and J. Bartek Adiponectin concentrations as a criterion of metabolic control in persons with type 2 diabetes mellitus? Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub. 147 2003 167 172
-
(2003)
Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub.
, vol.147
, pp. 167-172
-
-
Stejskal, D.1
Ruzicka, V.2
Adamovska, S.3
Jurakova, R.4
Proskova, J.5
Jedelsky, L.6
Bartek, J.7
-
29
-
-
63849269691
-
Echocardiographic assessment of global left ventricular function in mice
-
J. Stypmann, M.A. Engelen, C. Troatz, M. Rothenburger, L. Eckardt, and K. Tiemann Echocardiographic assessment of global left ventricular function in mice Lab. Anim. 43 2009 127 137
-
(2009)
Lab. Anim.
, vol.43
, pp. 127-137
-
-
Stypmann, J.1
Engelen, M.A.2
Troatz, C.3
Rothenburger, M.4
Eckardt, L.5
Tiemann, K.6
-
30
-
-
33846418746
-
Role of oxidative stress in cardiac hypertrophy and remodeling
-
DOI 10.1161/01.HYP.0000254415.31362.a7, PII 0000426820070200000001
-
E. Takimoto, and D.A. Kass Role of oxidative stress in cardiac hypertrophy and remodeling Hypertension 49 2007 241 248 (Pubitemid 46142995)
-
(2007)
Hypertension
, vol.49
, Issue.2
, pp. 241-248
-
-
Takimoto, E.1
Kass, D.A.2
-
31
-
-
0033515429
-
Deconstructing type 2 diabetes
-
S.I. Taylor Deconstructing type 2 diabetes Cell 97 1999 9 12 (Pubitemid 29165884)
-
(1999)
Cell
, vol.97
, Issue.1
, pp. 9-12
-
-
Taylor, S.I.1
-
32
-
-
84866356839
-
Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe (-/-) mice
-
F. Vittone, A. Liberman, D. Vasic, R. Ostertag, M. Esser, D. Walcher, A. Ludwig, N. Marx, and M. Burgmaier Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe (-/-) mice Diabetologia 55 2012 2267 2275
-
(2012)
Diabetologia
, vol.55
, pp. 2267-2275
-
-
Vittone, F.1
Liberman, A.2
Vasic, D.3
Ostertag, R.4
Esser, M.5
Walcher, D.6
Ludwig, A.7
Marx, N.8
Burgmaier, M.9
-
33
-
-
68549115434
-
High-cholesterol diet augments endothelial dysfunction via elevated oxidative stress and reduced tetrahydrobiopterin in Ins2(Akita) mice, an autosomal dominant mutant type 1 diabetic model
-
X.Q. Yang, and A.F. Chen High-cholesterol diet augments endothelial dysfunction via elevated oxidative stress and reduced tetrahydrobiopterin in Ins2(Akita) mice, an autosomal dominant mutant type 1 diabetic model Clin. Exp. Pharmacol. Physiol. 36 2009 764 769
-
(2009)
Clin. Exp. Pharmacol. Physiol.
, vol.36
, pp. 764-769
-
-
Yang, X.Q.1
Chen, A.F.2
-
34
-
-
0030907296
-
A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice
-
M. Yoshioka, T. Kayo, T. Ikeda, and A. Koizumi A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice Diabetes 46 1997 887 894 (Pubitemid 27188269)
-
(1997)
Diabetes
, vol.46
, Issue.5
, pp. 887-894
-
-
Yoshioka, M.1
Kayo, T.2
Ikeda, T.3
Koizumi, A.4
-
35
-
-
0035856920
-
Global and societal implications of the diabetes epidemic
-
DOI 10.1038/414782a
-
P. Zimmet, K.G. Alberti, and J. Shaw Global and societal implications of the diabetes epidemic Nature 414 2001 782 787 (Pubitemid 34000780)
-
(2001)
Nature
, vol.414
, Issue.6865
, pp. 782-787
-
-
Zimmet, P.1
Alberti, K.G.M.M.2
Shaw, J.3
|